Vistagen Therapeutics (VTGN) R&D In Process (2020 - 2021)
Historic R&D In Process for Vistagen Therapeutics (VTGN) over the last 4 years, with Q2 2021 value amounting to $5.6 million.
Historic R&D In Process for Vistagen Therapeutics (VTGN) over the last 4 years, with Q2 2021 value amounting to $5.6 million.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month